FDA.reportPublic FDA data

palovarotene 2.5 MG Oral Capsule

RxCUI
2663976
RxNorm name
palovarotene 2.5 MG Oral Capsule
Display name
palovarotene 2.5 MG Oral Capsule
Full name
palovarotene 2.5 MG Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
67dce406-7cc4-4d66-92de-ad18b6df0625palovarotene 2.5 MG Oral Capsule [PSN] · palovarotene 2.5 MG Oral Capsule [SCD] · palovarotene 2.5 MG Oral Capsule [SY]32These highlights do not include all the information needed to use SOHONOS ® safely and effectively. See full prescribing information for SOHONOS. SOHONOS (palovarotene) capsules, for oral use Initial U.S. Approval: 202320250318